Clinical Trial Update: MK0767 Added to Insulin Therapy in Patients With Type 2 Diabetes (0767-030) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating MK0767 added to insulin therapy in adults with Type 2 diabetes has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Insulin (insulin)
• MK0767

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED